HomeCompareAUCUF vs MRK

AUCUF vs MRK: Dividend Comparison 2026

AUCUF yields 1239.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AUCUF wins by $125046389.16M in total portfolio value
10 years
AUCUF
AUCUF
● Live price
1239.00%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$125046389.21M
Annual income
$107,913,149,474,350.55
Full AUCUF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — AUCUF vs MRK

📍 AUCUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAUCUFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AUCUF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AUCUF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AUCUF
Annual income on $10K today (after 15% tax)
$105,315.33/yr
After 10yr DRIP, annual income (after tax)
$91,726,177,053,197.97/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, AUCUF beats the other by $91,726,177,044,601.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AUCUF + MRK for your $10,000?

AUCUF: 50%MRK: 50%
100% MRK50/50100% AUCUF
Portfolio after 10yr
$62523194.64M
Annual income
$53,956,574,742,232.16/yr
Blended yield
86.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AUCUF
No analyst data
Altman Z
47.4
Piotroski
2/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AUCUF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAUCUFMRK
Forward yield1239.00%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$125046389.21M$57.7K
Annual income after 10y$107,913,149,474,350.55$10,113.78
Total dividends collected$123772929.27M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AUCUF vs MRK ($10,000, DRIP)

YearAUCUF PortfolioAUCUF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$134,600$123,900.38$11,213$373.04+$123.4KAUCUF
2$1,702,624$1,558,601.80$12,667$512.06+$1.69MAUCUF
3$20,247,504$18,425,696.05$14,439$708.14+$20.23MAUCUF
4$226,447,316$204,782,486.56$16,640$988.16+$226.43MAUCUF
5$2,382,746,813$2,140,448,184.79$19,432$1,394.07+$2382.73MAUCUF
6$23,598,548,465$21,049,009,374.98$23,057$1,992.90+$23598.53MAUCUF
7$220,080,198,594$194,829,751,737.21$27,889$2,894.79+$220080.17MAUCUF
8$1,933,601,124,954$1,698,115,312,458.12$34,518$4,286.29+$1933601.09MAUCUF
9$16,012,373,589,284$13,943,420,385,583.27$43,912$6,494.35+$16012373.55MAUCUF
10$125,046,389,214,884$107,913,149,474,350.55$57,714$10,113.78+$125046389.16MAUCUF

AUCUF vs MRK: Complete Analysis 2026

AUCUFStock

Inflection Resources Ltd., a junior resource company, engages in the exploration and evaluation of mineral properties in New South Wales and Queensland, Australia. It primarily explores for gold and copper deposits. The company holds interests in a portfolio of exploration licenses and applications totaling approximately 7,000 square kilometers. Its principal property is the Northern New South Wales project consisting of twenty-three non-contiguous exploration licenses and applications located in the Lachlan Fold Belt region of New South Wales, Australia. Inflection Resources Ltd. was incorporated in 2017 and is based in Vancouver, Canada.

Full AUCUF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AUCUF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AUCUF vs SCHDAUCUF vs JEPIAUCUF vs OAUCUF vs KOAUCUF vs MAINAUCUF vs JNJAUCUF vs ABBVAUCUF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.